<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融投资 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-03T16:18:54+08:00</updated>
  <subtitle>医药行业</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>吸入制剂流量药企：长风科创板辅导上市！</title>
    <updated>2020-12-03T15:13:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/G0YLYZ6PLizWhpE6VsjAgg</id>
    <link href="https://mp.weixin.qq.com/s/G0YLYZ6PLizWhpE6VsjAgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>氘代新药企业：海创科创板辅导上市中</title>
    <updated>2020-12-03T15:13:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/8oFd1-XWdHoFeVb0wSipCA</id>
    <link href="https://mp.weixin.qq.com/s/8oFd1-XWdHoFeVb0wSipCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同源康医药完成B轮融资，加速推进肿瘤管线</title>
    <updated>2020-12-02T14:26:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/xmXrYLPhhQIlbF4KOvLqzw</id>
    <link href="https://mp.weixin.qq.com/s/xmXrYLPhhQIlbF4KOvLqzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大盘点：中国对海外药企，新药授权初露端倪</title>
    <updated>2020-12-02T14:26:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/NJySa_yvSAfTkTlf9Y5Wcw</id>
    <link href="https://mp.weixin.qq.com/s/NJySa_yvSAfTkTlf9Y5Wcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药首个欧洲临床试验启动，Bcl-2抑制剂APG-2575！</title>
    <updated>2020-11-25T10:43:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/6xMxq4T70oTT9A4nX4KsqQ</id>
    <link href="https://mp.weixin.qq.com/s/6xMxq4T70oTT9A4nX4KsqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石家庄：免费制剂技术会议，你来不来？</title>
    <updated>2020-11-25T10:43:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/t_C4ZOtuRpF9hebUbcJo2A</id>
    <link href="https://mp.weixin.qq.com/s/t_C4ZOtuRpF9hebUbcJo2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>资本追逐的基因治疗赛道：和元生物上市辅导</title>
    <updated>2020-11-20T14:07:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/HjWvd6tbZiK1M01aDc1xSA</id>
    <link href="https://mp.weixin.qq.com/s/HjWvd6tbZiK1M01aDc1xSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基石投资大牌云集，德琪医药上市首日涨幅仅2%</title>
    <updated>2020-11-20T14:07:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/0n4Wm3904c1FLHI_IR3FBg</id>
    <link href="https://mp.weixin.qq.com/s/0n4Wm3904c1FLHI_IR3FBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大卖25亿美元GLP-1 ： Semaglutide获治疗NASH突破性疗法资格</title>
    <updated>2020-11-16T13:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/aq_aJs01cmj3jZi__iRQLw</id>
    <link href="https://mp.weixin.qq.com/s/aq_aJs01cmj3jZi__iRQLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国新药研发烧钱之最：百济神州拟科创板IPO</title>
    <updated>2020-11-16T13:40:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/klYLwGKv1eOH_cMQrjjvzg</id>
    <link href="https://mp.weixin.qq.com/s/klYLwGKv1eOH_cMQrjjvzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>微芯生物最新调研：在研多进展，未来可期</title>
    <updated>2020-11-10T16:44:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/rK1klcQkqw2Iu8x-RYGfuA</id>
    <link href="https://mp.weixin.qq.com/s/rK1klcQkqw2Iu8x-RYGfuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田：炎性肠病重磅Vedolizumab上半年大卖20亿美元；国内开售</title>
    <updated>2020-11-10T16:44:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/mVEWhIQDXbO3Yx4VhHfYmw</id>
    <link href="https://mp.weixin.qq.com/s/mVEWhIQDXbO3Yx4VhHfYmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大卖25亿美元GLP-1 ： Semaglutide获治疗NASH突破性疗法资格</title>
    <updated>2020-11-10T16:37:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/ak7Q7dBh9TTdFxNQL0Lt9Q</id>
    <link href="https://mp.weixin.qq.com/s/ak7Q7dBh9TTdFxNQL0Lt9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BMS原创氘代TYK2新药，3期银屑病临床击败阿普斯特</title>
    <updated>2020-11-10T16:37:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/q7GKPly081YNWNFZ0iiWTw</id>
    <link href="https://mp.weixin.qq.com/s/q7GKPly081YNWNFZ0iiWTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内在研火热：标配BCL-2+BTK；礼来重金引进复创新药！</title>
    <updated>2020-11-05T15:23:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/WE3ObSnajokRIhUmk0PwMw</id>
    <link href="https://mp.weixin.qq.com/s/WE3ObSnajokRIhUmk0PwMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超低调：新和成控股又一力作，福元医药拟科创板IPO</title>
    <updated>2020-11-05T15:23:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/fV_r3nYR43LxtcCgK_m-5A</id>
    <link href="https://mp.weixin.qq.com/s/fV_r3nYR43LxtcCgK_m-5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干眼症市场火热 | 新药EYSUVIS获批，股票却大跌</title>
    <updated>2020-11-03T11:21:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/WnaqiR4Bm3bZLGTZmPCnmg</id>
    <link href="https://mp.weixin.qq.com/s/WnaqiR4Bm3bZLGTZmPCnmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恩格列净：在华递交心衰适应症NDA；化合物专利被无效</title>
    <updated>2020-11-03T11:21:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/dJQ6oZDyQibHfODvMs7bXg</id>
    <link href="https://mp.weixin.qq.com/s/dJQ6oZDyQibHfODvMs7bXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多肽药物的江湖 | 创仿药/API/CDMO齐发力</title>
    <updated>2020-11-02T13:13:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/S5RjfAILgOsbUJzVTEMKKg</id>
    <link href="https://mp.weixin.qq.com/s/S5RjfAILgOsbUJzVTEMKKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>道尔生物完成近亿元A+轮融资，推进多特异新药研发</title>
    <updated>2020-11-02T13:13:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/XfnMSsFNAmqKPzDErPXMpQ</id>
    <link href="https://mp.weixin.qq.com/s/XfnMSsFNAmqKPzDErPXMpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>